Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper roundup: Vectura, Sunak, Cobham

Sun, 18th Jul 2021 11:35

(Sharecast News) - "The head of Marlboro cigarette-maker Philip Morris International (PMI) has hit out at critics of a controversial swoop on a healthcare company, claiming that the acquisition will help achieve its target to make the UK smoke-free within a decade. In the wake of fierce opposition to the deal to buy FTSE 250 inhaler-maker Vectura, André Calantzopoulos, PMI's executive chairman, said the "obsessive focus" by anti-smoking campaigners on Big Tobacco was the "wrong approach", adding that PMI has the "ability and the technology" to address harm from smoking." - Sunday Telegraph
Boris Johnson and Rishi Sunak have been forced to U-turn on using a pilot scheme to avoid self-isolation after coming into contact with coronavirus. Downing Street announced early today that the prime minister and chancellor would not be following the normal rules despite having been identified as close contacts of Sajid Javid, the health secretary, who tested positive for coronavirus yesterday. They changed course within three hours after broad criticism, meaning Johnson will isolate at his Chequers retreat until next Monday. - Sunday Times

The US private equity owners of Cobham have received a bumper payout from the aerospace specialist, sparking renewed anger over last year's £4billion takeover. Advent International bought the defence firm in January 2020 after an 18-month tussle with the founding family. It then began a dismantling of the group. Now the latest accounts show Cobham Limited will pay a £42.2million dividend for 2020, rocketing from £9.5million the year before. - Financial Mail On Sunday

Revolut is considering a London Stock Exchange listing after becoming the most valuable tech company ever in Britain, the MoS can reveal. The financial 'super app' last week fetched a blockbuster valuation of $33billion (£24billion), bigger than NatWest, after an $800million fundraising from private equity giants Softbank and Tiger Global. The $33billion price tag is six times bigger than its last funding round early last year, when founder Nikolay Storonsky, 36, became one of Britain's youngest billionaires. - Financial Mail on Sunday

In January, Entain - which also owns Coral, Gala Bingo and Sportingbet - rejected an £8billion all-share offer from US-based casino giant MGM Resorts International. The collapse of the negotiations led to MGM dropping its pursuit. Under Takeover Panel rules it was prevented from returning with a fresh bid for six months. The restriction on MGM ends tomorrow, leading to heated speculation in the City that the American group is preparing a new takeover offer for the FTSE100-listed firm. - Financial Mail on Sunday

Rishi Sunak faces an extra £10bn bill over the next two years as inflation surges, driving up interest bills on Government debts that are linked to the cost of living. About a quarter of the Government's debt, amounting to £460bn, is tied to the retail price index (RPI) measure of inflation, so the Treasury must pay out more money to savers and investors when prices rise. The Office for Budget Responsibility in March predicted RPI inflation would peak at 3.1pc in the second quarter of this year. - Sunday Telegraph

Morrisons is testing supermarkets with no checkouts or staff that would let customers simply walk out with their bag of shopping in a move to rival Amazon's Fresh stores. The grocer, which is the subject of a multi-billion pound takeover tussle, has been testing the concept known internally as Project Sarah at its Bradford head office. The store is open to thousands of staff and the FTSE 100 retailer plans to expand the idea more widely. Britain's fourth-largest supermarket is working with US technology company AiFi, which uses cameras to track the objects customers pick up and put in their baskets, and charges them through a smartphone app. - Sunday Telegraph

Billionaire philanthropists George Soros and Bill Gates are part of a buyout of Bedford based developer of lateral flow tests. The founder of Microsoft founder joined the Soros Economic Development Fund in a deal to buy Mologic, which has developed 10-minute Covid tests that it aims to make for as little as $1. The consortium will pump £30m into Mologic to focus on the low-cost development of tropical diseases such as dengue fever and river blindness, taking it on from current owners Foresight Group LLP and Calculus Capital. - Sunday Telegraph

More News
26 Nov 2018 09:05

Vectura Discontinues VR375 As Phase Three Study Misses Endpoints

LONDON (Alliance News) - Respiratory disease-focused pharmaceutical firm Vectura Group PLC said on Monday its phase three study of VR375 in adult and adolescent patients with severe uncontrolled a

Read more
22 Oct 2018 08:59

Vectura Says New Chief Financial Officer Fry Has Started Week Early

LONDON (Alliance News) - Medical devices developer Vectura Group PLC said Monday Paul Fry will become chief financial officer immediately, rather than from Monday next week.Fry succeeds who

Read more
11 Sep 2018 09:40

Vectura Interim Loss Narrows On Higher Revenue And Lower Expenses

LONDON (Alliance News) - Pharmaceutical firm Vectura Group PLC on Tuesday said its loss narrowed in the first half of 2018 as it reduced operating costs.Pretax loss narrowed to GBP29.9 in a

Read more
11 Sep 2018 08:18

Vectura's solid interims turn focus further forward

(Sharecast News) - Vectura kept guidance for the full year unchanged as the inhaled medicines specialist reported robust revenue and said it has identified pipeline projects with potential annual sales of over $250m.

Read more
10 Sep 2018 12:49

Vectura Launches Flutiform Inhaler In The UK, Europe To Follow

LONDON (Alliance News) - Vectura Group PLC said Monday that it launched its flutiform k-haler, an inhaler to treat asthma, in the UK.The company said it expects further launches across to a

Read more
4 Sep 2018 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 5 SeptemberĀ Barratt DevelopmentsFull Year ResultsBreedon GroupHalf Year Year 6

Read more
23 Aug 2018 14:17

Thursday broker round-up

(Sharecast News) - TalkTalk: Barclays upgrades to overweight with a target price of 150p.

Read more
21 Aug 2018 12:31

Vectura concludes two paediatric studies into VR647

(Sharecast News) - Vectura announced the successful conclusion of two paediatric studies to support the potential use of VR647, its wholly-owned drug/device combination asset, on Tuesday.

Read more
21 Aug 2018 09:45

Vectura Group Gets Positive Results From VR647 Phase II Study

LONDON (Alliance News) - Vectura Group PLC said Tuesday that it received positive results form two paediatric studies of its VR647 inhalation system to manage asthma.The two studies, a and

Read more
17 May 2018 10:55

Vectura Group On Track To Achieve Expected Full-Year Revenue

LONDON (Alliance News) - Inhaled product design and development firm Vectura Group PLC said on Thursday based on its trading performance for the year-to-date revenue is currently in line with is a

Read more
11 May 2018 11:35

Nuformix Appoints Former Ventura Chief Executive To Board

LONDON (Alliance News) - Pharmaceutical company Nuformix PLC said Friday that it has appointed Christopher Blackwell, the former chief executive officer of Vectura Group PLC, as non-executive of a

Read more
10 May 2018 16:16

UK Shareholder Meetings Calendar - Next 7 Days

Friday 11 MayBBA AviationMan GroupRSA Insurance GroupJohn Wood Advanced 14 15 Pacific

Read more
24 Apr 2018 13:16

Sosei Group Confirms It Will Not Make Takeover Offer For Vectura

LONDON (Alliance News) - Japanese biotechnology firm Sosei Group Corp said on Tuesday, noting unspecified press reports, it does not intend to make an offer for Vectura Group PLC.Shares in

Read more
23 Apr 2018 09:55

Vectura Adds Ex-GSK And Sanofi Executive Whitaker To Board From June

LONDON (Alliance News) - Vectura PLC said Monday it has appointed Anne Whitaker as non-executive director of the drug development firm from the start of June.Whitaker served as president of

Read more
20 Apr 2018 09:59

Vectura CFO Andrew Derodra Leaves To Take Up Role At Unilabs

LONDON (Alliance News) - Vectura Group PLC on Friday said that its Chief Financial Officer Andrew Derodra will leave the FTSE 250-listed respiratory medicines maker to take a new role within the a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.